Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep-Oct;28(5):101120.
doi: 10.1016/j.aohep.2023.101120. Epub 2023 Jun 2.

Examining genetic associations with hepatic steatosis in Mexican-origin adults

Mario Jesus Trejo  1 , Kristin E Morrill  2 , Yann C Klimentidis  3 , David O Garcia  4
Affiliations

Examining genetic associations with hepatic steatosis in Mexican-origin adults

Mario Jesus Trejo et al. Ann Hepatol. 2023 Sep-Oct.

Abstract

Introduction and objectives: Various studies have identified single-nucleotide polymorphisms (SNPs) associated with nonalcoholic fatty liver disease (NAFLD) and related traits, including ones located in or near the LYPLAL1, GCKR, PPP1R3B, TM6SF2, MBOAT7, and PNPLA3 genes. However, these SNPs were identified primarily in populations of European ancestry. This study examined the associations of these previously identified SNPs with hepatic steatosis in a sample of Mexican-origin adults living in Southern Arizona.

Materials and methods: A total of 307 Mexican-origin adults between the ages of 18 and 64 with a body mass index (BMI) of 25 kg/m2 or higher were genotyped at the following SNPs: rs12137855 (LYPLAL1), rs1260326 (GCKR), rs4240624 (PPP1R3B), rs58542926 (TM6SF2), rs641738 (MBOAT7), and rs738409 (PNPLA3). Hepatic steatosis was assessed by transient elastography (FibroScan®) with controlled attenuation parameter. Regression models examined the association between each of the six SNPs and hepatic steatosis. BMI was examined as a potential modifier of the genetic associations.

Results: Participants were, on average, 45 years old and mostly female (63%) with an overall mean hepatic steatosis of 288.1 dB/m. Models showed no associations between LYPLAL1, GCKR, PPP1R3B, TM6SF2, or MBOAT7 and hepatic steatosis. Only PNPLA3 was statistically significantly associated with hepatic steatosis in both unadjusted and adjusted models (p<0.01). There was no effect modification observed with BMI.

Conclusions: SNPs associated with NAFLD in populations of European descent did not strongly contribute to hepatic steatosis in individuals of Mexican-origin, except for rs738409 (PNPLA3). Further efforts are necessary to explore additional SNPs that may be associated with NAFLD in this high-risk population.

Keywords: NAFLD; Nonalcoholic fatty liver disease; SNPs.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests None.

Figures

Fig. 1.
Fig. 1.
Study flow diagram.
See this image and copyright information in PMC

References

    1. Lazo M, Bilal U, Perez-Escamilla R. Epidemiology of NAFLD and Type 2 diabetes: health disparities among persons of hispanic origin. Curr Diab Rep 2015;15(12):116. 10.1007/s11892-015-0674-6. - DOI - PubMed
    1. Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the american association for the study of liver diseases. Hepatology 2018;67(1):328–57. 10.1002/hep.29367. - DOI - PubMed
    1. Mazzolini G, Sowa JP, Atorrasagasti C, Kücükoglu Ö, Syn WK, Canbay A. Significance of simple steatosis: an update on the clinical and molecular evidence. Cells 2020;9(11). 10.3390/cells9112458. - DOI - PMC - PubMed
    1. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M Global epidemiology of nonalcoholic fatty liver disease—Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64(1):73–84. https://doi.org/10.1002/hep.28431. - DOI - PubMed
    1. Miller KD, Goding Sauer A, Ortiz AP, Fedewa SA, Pinheiro PS, Tortolero-Luna G, et al. Cancer statistics for hispanics/latinos, 2018. CA Cancer J Clin 2018;68(6):425–45. 10.3322/caac.21494. - DOI - PubMed